% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Amin:140000,
author = {Amin, Ehsan and Dubey, Badri Nath and Zhang, Si-Cai and
Gremer, Lothar and Dvorsky, Radovan and Moll, Jens M. and
Taha, Mohamed S. and Nagel-Steger, Luitgard and Piekorz,
Roland P. and Somlyo, Avril V. and Ahmadian, Mohammad R.},
title = {{R}ho-kinase: regulation, (dys)function, and inhibition},
journal = {Biological chemistry},
volume = {394},
number = {11},
issn = {1437-4315},
address = {Berlin [u.a.]},
publisher = {de Gruyter},
reportid = {FZJ-2013-05967},
pages = {1399-1410},
year = {2013},
abstract = {In a variety of normal and pathological cell types,
Rho-kinases I and II (ROCKI/II) play a pivotal role in the
organization of the nonmuscle and smooth muscle cytoskeleton
and adhesion plaques as well as in the regulation of
transcription factors. Thus, ROCKI/II activity regulates
cellular contraction, motility, morphology, polarity, cell
division, and gene expression. Emerging evidence suggests
that dysregulation of the Rho-ROCK pathways at different
stages is linked to cardiovascular, metabolic, and
neurodegenerative diseases as well as cancer. This review
focuses on the current status of understanding the multiple
functions of Rho-ROCK signaling pathways and various modes
of regulation of Rho-ROCK activity, thereby orchestrating a
concerted functional response.},
cin = {ICS-6},
ddc = {540},
cid = {I:(DE-Juel1)ICS-6-20110106},
pnm = {452 - Structural Biology (POF2-452)},
pid = {G:(DE-HGF)POF2-452},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000325717100005},
doi = {10.1515/hsz-2013-0181},
url = {https://juser.fz-juelich.de/record/140000},
}